Berberine-induced glucagon-like peptide-1 and its mechanism for controlling type 2 diabetes mellitus: a comprehensive pathway review
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Berberine-induced glucagon-like peptide-1 and its mechanism for controlling type 2 diabetes mellitus: a comprehensive pathway review
Authors
Keywords
-
Journal
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY
Volume -, Issue -, Pages 1-8
Publisher
Informa UK Limited
Online
2023-11-03
DOI
10.1080/13813455.2023.2258559
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety and Efficacy of Various Intravenous Insulin Infusion Rates in Patients With and Without Diabetes Presenting With Hypertriglyceridemia
- (2022) Francisco Ibarra et al. ANNALS OF PHARMACOTHERAPY
- Shenlian (SL) Decoction, a Traditional Chinese Medicine Compound, May Ameliorate Blood Glucose via Mediating the Gut Microbiota in db/db Mice
- (2022) Rui-xi Sun et al. Journal of Diabetes Research
- Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019
- (2022) Ewerton Cousin et al. Lancet Diabetes & Endocrinology
- Berberine Slows the Progression of Prediabetes to Diabetes in Zucker Diabetic Fatty Rats by Enhancing Intestinal Secretion of Glucagon-Like Peptide-2 and Improving the Gut Microbiota
- (2021) Ying Wang et al. Frontiers in Endocrinology
- Berberine activates the β-catenin/TCF4 signaling pathway by down-regulating miR-106b to promote GLP-1 production by intestinal L cells
- (2021) Jiao Wang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Ileal microbial shifts after Roux-en-Y gastric bypass orchestrate changes in glucose metabolism through modulation of bile acids and L-cell adaptation
- (2021) Jerry T. Dang et al. Scientific Reports
- Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study)
- (2020) Yifei Zhang et al. Nature Communications
- Berberine compounds improves hyperglycemia via microbiome mediated colonic TGR5-GLP pathway in db/db mice
- (2020) Meng Li et al. BIOMEDICINE & PHARMACOTHERAPY
- Reversal of metabolic disorders by pharmacological activation of bile acid receptors TGR5 and FXR
- (2018) Kavita Jadhav et al. Molecular Metabolism
- Restoration of GLP-1 secretion by Berberine is associated with protection of colon enterocytes from mitochondrial overheating in diet-induced obese mice
- (2018) Yongning Sun et al. Nutrition & Diabetes
- Gut microbiome and type 2 diabetes: where we are and where to go?
- (2018) Sapna Sharma et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Repertoire of human gut microbes
- (2017) Perrine Hugon et al. MICROBIAL PATHOGENESIS
- Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels
- (2017) Jian Hui Xu et al. Molecular Medicine Reports
- Mitochondrial flashes regulate ATP homeostasis in the heart
- (2017) Xianhua Wang et al. eLife
- Functional and Molecular Adaptations of Enteroendocrine L-Cells in Male Obese Mice Are Associated With Preservation of Pancreatic α-Cell Function and Prevention of Hyperglycemia
- (2016) Rodolphe Dusaulcy et al. ENDOCRINOLOGY
- Modulation of Microbiota-Gut-Brain Axis by Berberine Resulting in Improved Metabolic Status in High-Fat Diet-Fed Rats
- (2016) Honglin Sun et al. Obesity Facts
- Berberine induces GLP-1 secretion through activation of bitter taste receptor pathways
- (2015) Yunli Yu et al. BIOCHEMICAL PHARMACOLOGY
- Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension
- (2015) Jiarong Lan et al. JOURNAL OF ETHNOPHARMACOLOGY
- Berberine moderates glucose metabolism through the GnRH-GLP-1 and MAPK pathways in the intestine
- (2014) Qian Zhang et al. BMC Complementary and Alternative Medicine
- GLP-1 Agonism Stimulates Brown Adipose Tissue Thermogenesis and Browning Through Hypothalamic AMPK
- (2014) D. Beiroa et al. DIABETES
- Berberine decreases cholesterol levels in rats through multiple mechanisms, including inhibition of cholesterol absorption
- (2014) Yanwen Wang et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Gut microbiota and GLP-1
- (2014) Amandine Everard et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- Inhibition of ATPIF1 Ameliorates Severe Mitochondrial Respiratory Chain Dysfunction in Mammalian Cells
- (2014) Walter W. Chen et al. Cell Reports
- Inhibiting Roles of Berberine in Gut Movement of Rodents are Related to Activation of the Endogenous Opioid System
- (2013) Yajing Feng et al. PHYTOTHERAPY RESEARCH
- Effect of a glucagon-like peptide 1 analog, ROSE-010, on GI motor functions in female patients with constipation-predominant irritable bowel syndrome
- (2012) Michael Camilleri et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Inflammation and Lipid Signaling in the Etiology of Insulin Resistance
- (2012) Christopher K. Glass et al. Cell Metabolism
- A metagenome-wide association study of gut microbiota in type 2 diabetes
- (2012) Junjie Qin et al. NATURE
- Gut microbiota and diabetes: from pathogenesis to therapeutic perspective
- (2011) Rémy Burcelin et al. ACTA DIABETOLOGICA
- Berberine protects against high fat diet-induced dysfunction in muscle mitochondria by inducing SIRT1-dependent mitochondrial biogenesis
- (2011) Ana P. Gomes et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Berberine Improves Glucose Metabolism in Diabetic Rats by Inhibition of Hepatic Gluconeogenesis
- (2011) Xuan Xia et al. PLoS One
- Effects and Action Mechanisms of Berberine and Rhizoma coptidis on Gut Microbes and Obesity in High-Fat Diet-Fed C57BL/6J Mice
- (2011) Weidong Xie et al. PLoS One
- Prebiotic effects: metabolic and health benefits
- (2010) Marcel Roberfroid et al. BRITISH JOURNAL OF NUTRITION
- The gut microbiota ecology: a new opportunity for the treatment of metabolic diseases ?
- (2010) Remy Burcelin Frontiers in Bioscience-Landmark
- Berberine suppresses intestinal disaccharidases with beneficial metabolic effects in diabetic states, evidences from in vivo and in vitro study
- (2010) Li Liu et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Effect of berberine and Berberis aetnensis C. Presl. alkaloid extract on glutamate-evoked tissue transglutaminase up-regulation in astroglial cell cultures
- (2010) Agata Campisi et al. PHYTOTHERAPY RESEARCH
- Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal
- (2009) Patrice D Cani et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Modulation of glucagon-like peptide-1 release by berberine: In vivo and in vitro studies
- (2009) Yunli Yu et al. BIOCHEMICAL PHARMACOLOGY
- TGR5-Mediated Bile Acid Sensing Controls Glucose Homeostasis
- (2009) Charles Thomas et al. Cell Metabolism
- Berberine Differentially Modulates the Activities of ERK, p38 MAPK, and JNK to Suppress Th17 and Th1 T Cell Differentiation in Type 1 Diabetic Mice
- (2009) Guoliang Cui et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression
- (2009) Hao Zhang et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Acetylcholinesterase inhibitory guided fractionation of Melissa officinalis L.
- (2008) Keyvan Dastmalchi et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Berberine and Its More Biologically Available Derivative, Dihydroberberine, Inhibit Mitochondrial Respiratory Complex I: A Mechanism for the Action of Berberine to Activate AMP-Activated Protein Kinase and Improve Insulin Action
- (2008) N. Turner et al. DIABETES
- Treatment of Type 2 Diabetes and Dyslipidemia with the Natural Plant Alkaloid Berberine
- (2008) Yifei Zhang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Incretins: pathophysiological and therapeutic implications of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1
- (2008) L R Ranganath JOURNAL OF CLINICAL PATHOLOGY
- Efficacy of berberine in patients with type 2 diabetes mellitus
- (2008) Jun Yin et al. METABOLISM-CLINICAL AND EXPERIMENTAL
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started